BrightPath Biotherapeutics Co., Ltd

4594・Growth Market・Pharmaceuticals

4594・Growth Market・Pharmaceuticals

BrightPath Biotherapeutics Co., Ltd4594

Reference Indicators

Market Cap

65¥100M

P/E (Forecast)

—

P/B

2.8x

Dividend Yield (Forecast)

0.00%

ROE

-55.6%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	15	5	0	1	0
Cost of Sales	3	1	0	0	0
Gross Profit	12	3	0	1	0
SG&A Expenses	1,488	1,470	1,155	1,162	1,295
Operating Income	-1,476	-1,467	-1,155	-1,160	-1,295
Non-operating Income	0	0	0	17	18
Non-operating Expenses	6	7	4	4	16
Ordinary Income	-1,481	-1,473	-1,158	-1,147	-1,293
Extraordinary Income	5	—	—	—	0
Extraordinary Losses	5	9	7	1	9
Pre-tax Income	-1,481	-1,483	-1,166	-1,149	-1,302
Income Taxes	2	1	1	1	2
Net Income	-1,484	-1,485	-1,168	-1,151	-1,304
EBITDA	-1,440	-1,450	-1,154	—	—
Gross Margin	78.5%	64.1%	75.0%	97.2%	64.3%
Operating Margin	-9579.7%	-27785.2%	-1604275.0%	-102464.1%	-1541667.9%
ROA	-53.6%	-87.3%	-94.9%	-102.7%	-50.1%
ROE	-59.2%	-96.0%	-122.2%	-127.4%	-55.6%

Disclaimer